- Peter Hellings – Lead
- Dermot Ryan – Vice Chair
- Antonella Muraro
- Ludger Klimek
- Pete Smith
- Simon Carney
- Richard Harvey
- Pascal Demoly
- Wytske Fokkens
- Glenis Scadding
- Claus Bachert
- Lars Olaf Cardell
- Ralph Mosges
- Magnus Wickman
- G Walter Canonica
- Erkka Valovirta
- Joaquim Mullol
- Phil Lieberman
- Eli Meltzer
- Fulvio Braido
- George Christoff
- Hae-Sim Park
- Kirsten Beyer
- Martin Church
- Renaud Louis
- Torsten Zuberbier
- Audrey Dunn Galvin
The most recent meeting took place during EAACI 2016 this June, in Vienna.
The Allergy Working Group also met in September 2015 at the time of the ERS in Amsterdam.
The REG Allergy Working Group will be presenting three posters at the 27th Annual Conference of the Australasian Society of Clinical Immunology and Allergy – ASCIA 2016.
The conference takes place from 14-17 September 2016 at the Gold Coast Convention Centre, Queensland, Australia.
The working group is currently collating research ideas following an inaugural meeting in June 2015 and is currently prioritising its core activities to reflect the opportunities to examine allergy within real-life respiratory research in a context that will benefit patient care and inform future guidelines.
IgE mediated sensitisation to aeroallergens in an asthmatic cohort: relationship with inflammatory phenotypes and disease severity.
Manise M, Bakayoko B, Schleich F, Corhay JL, Louis R.
Int J Clin Pract. 2016 Jul;70(7):596-605. doi: 10.1111/ijcp.12837.
EU Symposium Precision Medicine in Allergy and Airways Disease
REG was delighted and honoured to be represented by Prof. David Price at the European Academy of Allergy and Clinical, European Rhinologic Society and the European Medical Association European Symposium on Precision Medicine in Allergy and Airways Diseases. The meeting took place on 14th October 2015 at the European Parliament in Brussels and was the first visionary meeting on precision medicine in the field of the most prevalent non-communicable diseases in Europe, i.e. allergy and chronic airway diseases and aimed to:
- Demonstrate the need for precision medicine in allergy and chronic airways disease in Europe
- Define an action plan to deliver precision medicine in allergy and airways disease in Europe
You can watch the discussion online here:
We are looking forward to future meetings and will keep you updated on any developments.
Find out more on the EAACI website at http://eaaci.org/outreach/2015-09-07-11-06-14/eu-activities.html